Form 8-K - Current report:
SEC Accession No. 0001108205-25-000020
Filing Date
2025-02-27
Accepted
2025-02-27 16:03:07
Documents
13
Period of Report
2025-02-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K cris-20250221.htm   iXBRL 8-K 26409
  Complete submission text file 0001108205-25-000020.txt   152399

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20250221.xsd EX-101.SCH 1789
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20250221_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20250221_pre.xml EX-101.PRE 13054
15 EXTRACTED XBRL INSTANCE DOCUMENT cris-20250221_htm.xml XML 2821
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 25678570
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)